Genetic Core
遗传核心
基本信息
- 批准号:7667781
- 负责人:
- 金额:$ 20.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBackcrossingsBasic ScienceBiologicalCryopreservationDerivation procedureDisease modelES Cell LineEmbryoEquipmentExperimental ModelsFibroblastsFundingGenesGeneticGenomeGenotypeHuman ResourcesInbred StrainIndividualKnock-outKnockout MiceLaboratoriesMusProceduresProcessProductionProteinsPurposeRelative (related person)RheumatismRoleScientistServicesSpeedSystemTechniquesTransgenic Organismsblastocystcongenicexperimental analysisgenetic manipulationgenetic technologygenome sequencinginsightmouse modelmutantskills
项目摘要
Genetic manipulation of mouse models has been an extremely productive approach to studying basic
biological mechanisms. A Genetics Core has been established and has been productive during the last
funding period. The RDCC proposes to continue support of the Genetics Core to provide two major services:
1) Transgenic and knockout mouse production and 2) Speed congenics. The transgenic and knockout mouse
production facility provides additional services including blastocyst complementation, derivation of new
embryonic stem cell lines, cryopreservation, and mouse embryonic fibroblast production. The speed
congenics facility provides genome wide typing for the purposes of enhancing backcrossing of mice into
defined genetic backgrounds. Thus, the facility will enhance the study of basic mechanisms underlying
rheumatic diseases.
对小鼠模型进行遗传操作是研究基础疾病的一种极具成效的方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT DAVID SCHREIBER其他文献
ROBERT DAVID SCHREIBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT DAVID SCHREIBER', 18)}}的其他基金
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
基于基因组学的个性化癌症免疫治疗的发展
- 批准号:
8887618 - 财政年份:2015
- 资助金额:
$ 20.78万 - 项目类别:
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
基于基因组学的个性化癌症免疫治疗的发展
- 批准号:
9031745 - 财政年份:2015
- 资助金额:
$ 20.78万 - 项目类别:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
IFNα/β 和 IFNγ 在先天免疫中的组织特异性作用
- 批准号:
8234935 - 财政年份:2011
- 资助金额:
$ 20.78万 - 项目类别:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
IFNα/β 和 IFNγ 在先天免疫中的组织特异性作用
- 批准号:
7672130 - 财政年份:2009
- 资助金额:
$ 20.78万 - 项目类别:
The Molecular and Cellular Basis of Cancer Immunoediting
癌症免疫编辑的分子和细胞基础
- 批准号:
6771282 - 财政年份:2004
- 资助金额:
$ 20.78万 - 项目类别:
The Molecular and Cellular Basis of Cancer Immunoediting
癌症免疫编辑的分子和细胞基础
- 批准号:
7215633 - 财政年份:2004
- 资助金额:
$ 20.78万 - 项目类别:
The Molecular and Cellular Basis of Cancer Immunoediting
癌症免疫编辑的分子和细胞基础
- 批准号:
6888072 - 财政年份:2004
- 资助金额:
$ 20.78万 - 项目类别: